SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-100536
Filing Date
2020-04-07
Accepted
2020-04-07 17:04:52
Documents
6
Effectiveness Date
2020-04-07

Document Format Files

Seq Description Document Type Size
1 S-8 d914800ds8.htm S-8 61034
2 EX-4.1 d914800dex41.htm EX-4.1 28119
3 EX-4.2 d914800dex42.htm EX-4.2 214403
4 EX-5.1 d914800dex51.htm EX-5.1 11047
5 EX-23.1 d914800dex231.htm EX-23.1 1547
6 GRAPHIC g914800g0407122827477.jpg GRAPHIC 1785
  Complete submission text file 0001193125-20-100536.txt   319965
Mailing Address 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018
Business Address 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Filer) CIK: 0001725160 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-237593 | Film No.: 20780354
SIC: 2834 Pharmaceutical Preparations